This event provided an update on the latest developments in plasma supply in Europe, along with strategies to enhance and increase the safe collection and adequate supply of plasma and plasma-derived medicinal products (PDMP).

As part of a continuous effort to build upon recent and ongoing initiatives aimed at increasing and improving plasma collection and PDMP supply in European countries, and in the context of the changing regulatory landscape in the EU, this event covered the entire plasma-to-PDMP-to-patient chain.

Funders

The EDQM Stakeholder Event is co-funded by the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe and the European Commission (EC).

The EDQM is a major contributor to developing internationally recognised guidelines and providing capacity-building tools, thus acting as an essential partner for blood establishments in Europe and beyond. In collaboration with international experts, the EDQM actively supports progress in the field of substances of human origin by organising dedicated conferences and providing regular training courses on quality management.